Long non-coding RNA-HAGLR suppressed tumor growth of lung adenocarcinoma through epigenetically silencing E2F1

Area of Science:

• Molecular Biology
• Genetics
• Oncology

Background:

• Long noncoding RNAs (LncRNAs) are increasingly recognized for their roles in gene regulation.
• The specific mechanisms by which LncRNAs influence cancer development, particularly lung adenocarcinoma (LUAD), remain largely underexplored.

Purpose of the Study:

• To investigate the role of LncRNA alterations in lung adenocarcinoma (LUAD).
• To elucidate the functional and mechanistic basis of HAGLR in LUAD progression.

Main Methods:

• Analysis of publicly available microarray and RNA sequencing data from Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA).
• In vitro studies using LUAD cell lines and in vivo experiments in mouse models.
• Investigation of molecular interactions between HAGLR, DNMT1, and the E2F1 promoter.

Main Results:

• HAGLR (HOXD-AS1) was found to be frequently downregulated in LUAD tissues.
• Decreased HAGLR expression correlated with poorer survival outcomes in LUAD patients.
• HAGLR demonstrated tumor-suppressive effects by attenuating LUAD cell growth both in vitro and in vivo.
• Mechanistically, HAGLR interacts with DNMT1, recruiting it to the E2F1 promoter to increase DNA methylation and suppress E2F1 expression.

Conclusions:

• HAGLR acts as a tumor suppressor in LUAD by epigenetically silencing E2F1 through DNMT1 recruitment.
• The HAGLR-DNMT1-E2F1 axis represents a novel pathway in LUAD pathogenesis.
• These findings suggest HAGLR as a potential therapeutic target for LUAD treatment.